Selective and sustained inhibition of surface-bound thrombin activity by Intimatan/heparin cofactor II and its relevance to assessing systemic anticoagulation in vivo, ex vivo and in vitro

Thrombosis and Haemostasis

Volumn 86, Issue 3, 2001, Pages 909-913

  Buchanan, M R ^a   Maclean, G A ^a   Brister, S J ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Heparin; Intimatan; Surface bound thrombin

Indexed keywords

DERMATAN SULFATE DERIVATIVE; HEPARIN; HEPARIN COFACTOR II; INTIMATAN; THROMBIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ARTICLE; BLOOD VESSEL INJURY; CELL SURFACE; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG EFFECT; DRUG INHIBITION; ENZYME ACTIVITY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LIQUID; MALE; NONHUMAN; PHYSICAL PHASE; PRIORITY JOURNAL; THROMBOGENICITY;

EID: 0034857242     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616149     Document Type: Article

References (21)

1. Mitogenic activity of blood components. 1. Thrombin and prothrombin
2. Thrombin hypothesis of thrombus generation and vascular lesion formation
3. Inhibition of chronic vessel wall intimal hyperplasia following acute anticoagulant treatment: Relative effects of heparin and dermatan sulphate
4. Fibrin monomer protects thrombin from inactivation by heparin- antithrombin III: Implications for heparin efficacy
5. Binding of thrombin to subendothelial extracellular matrix
6. In vivo catalysis of thrombin inhibition by antithrombin III and heparin cofactor II and antithrombotic effect: Differential effects of dermatan sulphate and unfractionated heparin
7. Dermatan sulfate is a more potent inhibitor of clot bound thrombin than unfractionated and low molecular weight heparins
8. Thrombin-catalysed amplification and inhibitory reactions of blood coagulation
9. Molecular and cellular biology of blood coagulation
10. Dermatan sulfate, an inhibitor of thrombin generation and complement activation
11. Assay of plasma heparin using thrombin and the chromogenic substrate H-D-phe-pip-arg-p-NA (S2238)
12. Systemic and surface- bound thrombin activity: Implications for the assessment of the anticoagulant and antithrombotic effects of heparin, dermatan sulfate and Intimatan
13. The isolation of prothrombin, factor IX and factor X from human factor IX concentrates
14. Activation of heparin cofactor II by dermatan sulfate
15. Prolonged activation of prothrombin on the vascular wall after arterial injury
16. Heparin cofactor II is regulated allosterically and not primarily by template effects. Studies with mutant thrombins and glycosaminoglycans
17. Comparison of heparin- and dermatan sulfate-mediated catalysis of thrombin inactivation by heparin cofactor II
18. Heparinless cardiopulmonary bypass (CPB) revisited: A newer strategy to avoid CPB/heparin related bleeding
19. The antithrombotic and bleeding effects of glycosaminoglycans with different degrees of sulfation